Imperial Valley News Center
Washington, DC - Today the Federal Trade Commission announced that the agency has approved changes to the Fuel Economy Guide as part of Acting Chairman Maureen K. Ohlhausen’s regulatory reform initiative to keep pace with technological advances in the marketplace while continuing to protect consumers.
Washington, DC - In a pioneering effort to control, measure and understand magnetism at the atomic level, researchers working at the National Institute of Standards and Technology (NIST) have discovered a new method for manipulating the nanoscale properties of magnetic materials.
Washington, DC - This week, the Energy Department announced up to $32 million for seven Resilient Distribution Systems projects, which will support early stage research and development of next-generation tools and technologies that will further improve the resilience of the nation's electric grid. This is the second round of funding under the Department’s Grid Modernization Initiative, a DOE-wide collaboration primarily supported by the Office of Energy Efficiency and Renewable Energy (EERE) and the Office of Electricity Delivery and Energy Reliability.
Washington, DC - Secretary of State Rex W. Tillerson: "On behalf of the Government of the United States, we offer our best wishes to you and the people of Papua New Guinea as you celebrate your nation’s 42nd Independence Day on September 16.
San Diego Zoo, California - San Diego’s wildest tasting event, the San Diego Zoo Food, Wine & Brew Celebration presented by ASML/Cymer returns Saturday, September 23, 2017. Guests at the 37th annual event will enjoy a globally inspired, all-inclusive tasting event with more than 160 of Southern California's best restaurants, breweries, wineries and spirit vendors along with live entertainment, dancing and animal encounters inside the world-famous San Diego Zoo.
Washington, DC - The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment of cancer.